Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

NCT02579564 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Malignant Hydrothorax
Non Small Cell Lung Cancer

Interventions

DRUG: Gemcitabine
DRUG: Vinorelbine
DRUG: Paclitaxel
DRUG: Pemetrexed
DRUG: Oncorine
DRUG: Endostar
DRUG: Cisplatin

Sponsor

Xinqiao Hospital of Chongqing